170 related articles for article (PubMed ID: 23580381)
1. Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms.
Morgan CJ; Page E; Schaefer C; Chatten K; Manocha A; Gulati S; Curran HV; Brandner B; Leweke FM
Br J Psychiatry; 2013 May; 202(5):381-2. PubMed ID: 23580381
[TBL] [Abstract][Full Text] [Related]
2. Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use.
Leweke FM; Giuffrida A; Koethe D; Schreiber D; Nolden BM; Kranaster L; Neatby MA; Schneider M; Gerth CW; Hellmich M; Klosterkötter J; Piomelli D
Schizophr Res; 2007 Aug; 94(1-3):29-36. PubMed ID: 17566707
[TBL] [Abstract][Full Text] [Related]
3. Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis.
Koethe D; Giuffrida A; Schreiber D; Hellmich M; Schultze-Lutter F; Ruhrmann S; Klosterkötter J; Piomelli D; Leweke FM
Br J Psychiatry; 2009 Apr; 194(4):371-2. PubMed ID: 19336792
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms.
Giuffrida A; Leweke FM; Gerth CW; Schreiber D; Koethe D; Faulhaber J; Klosterkötter J; Piomelli D
Neuropsychopharmacology; 2004 Nov; 29(11):2108-14. PubMed ID: 15354183
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy.
Romigi A; Bari M; Placidi F; Marciani MG; Malaponti M; Torelli F; Izzi F; Prosperetti C; Zannino S; Corte F; Chiaramonte C; Maccarrone M
Epilepsia; 2010 May; 51(5):768-72. PubMed ID: 19817812
[TBL] [Abstract][Full Text] [Related]
6. Leptin levels are negatively correlated with 2-arachidonoylglycerol in the cerebrospinal fluid of patients with osteoarthritis.
Nicholson J; Azim S; Rebecchi MJ; Galbavy W; Feng T; Reinsel R; Rizwan S; Fowler CJ; Benveniste H; Kaczocha M
PLoS One; 2015; 10(4):e0123132. PubMed ID: 25835291
[TBL] [Abstract][Full Text] [Related]
7. Anandamide dysfunction in prodromal and established psychosis.
Leweke FM
Curr Pharm Des; 2012; 18(32):5188-93. PubMed ID: 22716147
[TBL] [Abstract][Full Text] [Related]
8. Quantitative profiling of endocannabinoids and related
Kantae V; Ogino S; Noga M; Harms AC; van Dongen RM; Onderwater GL; van den Maagdenberg AM; Terwindt GM; van der Stelt M; Ferrari MD; Hankemeier T
J Lipid Res; 2017 Mar; 58(3):615-624. PubMed ID: 27999147
[TBL] [Abstract][Full Text] [Related]
9. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study.
Chester LA; Englund A; Chesney E; Oliver D; Wilson J; Sovi S; Dickens AM; Oresic M; Linderman T; Hodsoll J; Minichino A; Strang J; Murray RM; Freeman TP; McGuire P
Cannabis Cannabinoid Res; 2024 Feb; 9(1):188-198. PubMed ID: 36493386
[No Abstract] [Full Text] [Related]
10. Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans.
Thieme U; Schelling G; Hauer D; Greif R; Dame T; Laubender RP; Bernhard W; Thieme D; Campolongo P; Theiler L
Drug Test Anal; 2014; 6(1-2):17-23. PubMed ID: 24424856
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis.
Di Filippo M; Pini LA; Pelliccioli GP; Calabresi P; Sarchielli P
J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1224-9. PubMed ID: 18535023
[TBL] [Abstract][Full Text] [Related]
12. Alterations of endocannabinoids in cerebrospinal fluid of dogs with epileptic seizure disorder.
Gesell FK; Zoerner AA; Brauer C; Engeli S; Tsikas D; Tipold A
BMC Vet Res; 2013 Dec; 9():262. PubMed ID: 24370333
[TBL] [Abstract][Full Text] [Related]
13. Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients.
Pisani V; Moschella V; Bari M; Fezza F; Galati S; Bernardi G; Stanzione P; Pisani A; Maccarrone M
Mov Disord; 2010 May; 25(7):920-4. PubMed ID: 20461809
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoids in chronic migraine: CSF findings suggest a system failure.
Sarchielli P; Pini LA; Coppola F; Rossi C; Baldi A; Mancini ML; Calabresi P
Neuropsychopharmacology; 2007 Jun; 32(6):1384-90. PubMed ID: 17119542
[TBL] [Abstract][Full Text] [Related]
15. Association of anandamide with altered binocular depth inversion illusion in schizophrenia.
Reuter AR; Bumb JM; Mueller JK; Rohleder C; Pahlisch F; Hanke F; Arens E; Leweke FM; Koethe D; Schwarz E
World J Biol Psychiatry; 2017 Sep; 18(6):483-488. PubMed ID: 27734750
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Walentiny DM; Vann RE; Wiley JL
Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
[TBL] [Abstract][Full Text] [Related]
17. Determination of anandamide in cerebrospinal fluid samples by disposable pipette extraction and ultra-high performance liquid chromatography tandem mass spectrometry.
Oliveira IGC; Marchioni C; Queiroz MEC
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Nov; 1130-1131():121809. PubMed ID: 31669634
[TBL] [Abstract][Full Text] [Related]
18. Familial abnormalities of endocannabinoid signaling in schizophrenia.
Koethe D; Pahlisch F; Hellmich M; Rohleder C; Mueller JK; Meyer-Lindenberg A; Torrey EF; Piomelli D; Leweke FM
World J Biol Psychiatry; 2019 Feb; 20(2):117-125. PubMed ID: 29521179
[TBL] [Abstract][Full Text] [Related]
19. Increased CB2 mRNA and anandamide in human blood after cessation of cannabis abuse.
Muhl D; Kathmann M; Hoyer C; Kranaster L; Hellmich M; Gerth CW; Faulhaber J; Schlicker E; Leweke FM
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):691-5. PubMed ID: 24788457
[TBL] [Abstract][Full Text] [Related]
20. The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation.
Smith M; Wilson R; O'Brien S; Tufarelli C; Anderson SI; O'Sullivan SE
PLoS One; 2015; 10(9):e0136546. PubMed ID: 26414859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
